Vinorelbine for Recurrent ALCL-2017

Clinical trial NCT03443128 · COMPLETED

Trial details

NCT number: NCT03443128
Sponsor: Children's Cancer Group, China
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anaplastic Large Cell Lymphoma Vinorelbine

Start date: 2016-11-01
Primary completion: 2024-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.